FDA Inspection
Oklahoma Blood InstituteOklahoma Blood Institute – FDA Inspection, Aug 20, 2015
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute, with an inspection on August 20, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Oklahoma Blood Institute
- Inspection Date
- August 20, 2015
- Product Type
- Biologics
View Company Profile
ID · c96c753d-4a80-4b39-ad43-26516fa74dd6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 945662
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oklahoma Blood Institute
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 20, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 7, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 20, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 7, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 11, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute
- FDA Inspection 1231637 - 2024-08-20
- FDA Inspection 1093994 - 2019-06-07
- FDA Inspection 1023507 - 2017-06-20
- FDA Inspection 876145 - 2014-05-07
- FDA Inspection 810435 - 2012-10-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.